We hosted Open Science in Brief on February 24, 2022. The event was hosted both on our Open Science platform and on PMIScience's Linkedin account.
Watch the replay where three of our leading scientists discuss the analysis of both targeted and untargeted screening of toxicants in the aerosols of smoke-free products and other alternatives.
...
PMI also takes a scientific approach to thinking about the future, including sustainability.
Real-world evidence not only adds to, but also improves the understanding of how switching to smoke-free products can impact public health
Read the technology behind our heated tobacco products
@PMIScience
Diego Marescotti, our Manager In Vitro #Pharmacology, will be talking at the upcoming Global Forum on Nicotine (GFN) taking place on 16-18 June. Find out more about GFN and join him ➡️ spr.ly/6019zJWR5
@PMIScience
🔊 on. Watch the highlights from the last #OpenScience event where Dr. Gizelle Baker speaks about this topic in detail ➡️ spr.ly/6011zJlUX
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.